Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
YH1 (Chang Gung Memorial Hospital)
- Development stage
- Unknown
- Lead developer
- Chang Gung Memorial Hospital
- Administration
- Oral
01
Overview
YH1 is an investigational concentrated herbal extract granule formulation developed by Chang Gung Memorial Hospital. It is being evaluated as an add-on therapy for patients with poorly controlled type 2 diabetes mellitus who are already receiving standard oral hypoglycemic agents. The drug is administered orally and is designed to enhance glycemic control, as measured by reductions in HbA1c, fasting plasma glucose, and postprandial glucose levels. Clinical evaluation also includes its effects on insulin resistance, beta-cell function, and lipid profiles.
- Other names
- YH1 herbal granulesYH-1 herbal granulesYH 1 herbal granules
Beyond the preview
Go deeper on YH1 (Chang Gung Memorial Hospital).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on YH1 (Chang Gung Memorial Hospital).